Clal Biotechnology Industries Ltd. (CBI)

Overview

Clal Biotechnology Industries Ltd. is a distinguished private equity and venture capital firm primarily focused on fueling the growth of companies within the life sciences sector. Founded in July 1998 and headquartered in Tel Aviv, Israel, this firm offers a wide range of financing stages, from development, pre-clinical and incubation phases through to seed, start-up, early venture, emerging growth, mid-venture, late venture, PIPEs (Private Investment in Public Equity), and growth capital investments. With a strategic interest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology, Clal Biotechnology Industries Ltd. positions itself as a crucial player in the advancement of healthcare innovation. While its primary focus is on companies based in the United States and Israel, its approach is global in ensuring the development and accessibility of groundbreaking healthcare solutions. Clal Biotechnology Industries Ltd. also emphasizes a hands-on investment approach by securing a seat on the board of directors of its portfolio companies, thereby contributing managerial and strategic expertise in addition to financial support. Operating as a lead investor and major shareholder, its investment philosophy is marked by a deep commitment to the growth and success of its ventures. Historically linked with Clal Industries and Investments Ltd. as a former subsidiary, Clal Biotechnology Industries Ltd. has expanded its footprint beyond its roots in Tel Aviv to include offices in Boston and Cambridge, Massachusetts, thereby reinforcing its presence in key global biotech hubs.

Products and Services

Clal Biotechnology Industries Ltd. provides an array of services and investment opportunities designed to support and accelerate the growth of innovative companies within the life sciences sector:

• Development Stage Financing: Support for companies in the pre-clinical or initial development phases to transition their research into viable products.
• Incubation and Seed Funding: Early-stage financial and strategic assistance for startups in their most vulnerable initial phases, focusing on establishing a solid foundation for future growth.
• Start-up and Early Venture Support: Investments and resources aimed at companies transitioning from concept to early market presence, bolstering their ability to achieve significant milestones.
• Emerging Growth and Mid-Venture Financing: For companies that have demonstrated market potential and are in need of capital to scale operations, expand market reach, or enhance product offerings.
• Late Venture and PIPEs: Providing growth capital for more established companies looking to expand further or explore new markets, including private investment in public equity to support transitions to public ownership.
• Growth Capital: Financial investments tailored to support significant expansion endeavors of high-performing companies aiming for a larger scale operation.
• Board Participation: Beyond financial investment, Clal Biotechnology Industries Ltd. offers managerial guidance and strategic oversight through active participation on the boards of its portfolio companies.
• Lead Investor Role: Leading financing rounds to ensure adequate capital raising and investment attraction, signaling confidence and stability to other potential investors.